Axim Biotechnologies Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.11 |
Market Cap |
$50.49 M |
Shares Outstanding |
61.57 M |
Public Float |
12.42 M |
Address |
45 Rockefeller Plaza New York New York 10111 United States |
Employees | - |
Website | http://www.aximbiotech.com |
Updated | 07/08/2019 |
AXIM Biotechnologies, Inc. engages in the research, development, and production of pharmaceutical, nutraceutical, cosmetic, and genetically controlled botanical products. The firm also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand; and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand. |